275 related articles for article (PubMed ID: 17141748)
1. Tissue factor induction by aggregated LDL depends on LDL receptor-related protein expression (LRP1) and Rho A translocation in human vascular smooth muscle cells.
Camino-López S; Llorente-Cortés V; Sendra J; Badimon L
Cardiovasc Res; 2007 Jan; 73(1):208-16. PubMed ID: 17141748
[TBL] [Abstract][Full Text] [Related]
2. Aggregated low-density lipoprotein uptake induces membrane tissue factor procoagulant activity and microparticle release in human vascular smooth muscle cells.
Llorente-Cortés V; Otero-Viñas M; Camino-López S; Llampayas O; Badimon L
Circulation; 2004 Jul; 110(4):452-9. PubMed ID: 15238452
[TBL] [Abstract][Full Text] [Related]
3. Sterol regulatory element binding proteins downregulate LDL receptor-related protein (LRP1) expression and LRP1-mediated aggregated LDL uptake by human macrophages.
Llorente-Cortés V; Royo T; Otero-Viñas M; Berrozpe M; Badimon L
Cardiovasc Res; 2007 Jun; 74(3):526-36. PubMed ID: 17376415
[TBL] [Abstract][Full Text] [Related]
4. Angiotensin II upregulates LDL receptor-related protein (LRP1) expression in the vascular wall: a new pro-atherogenic mechanism of hypertension.
Sendra J; Llorente-Cortés V; Costales P; Huesca-Gómez C; Badimon L
Cardiovasc Res; 2008 Jun; 78(3):581-9. PubMed ID: 18281370
[TBL] [Abstract][Full Text] [Related]
5. Cholesteryl esters of aggregated LDL are internalized by selective uptake in human vascular smooth muscle cells.
Llorente-Cortés V; Otero-Viñas M; Camino-López S; Costales P; Badimon L
Arterioscler Thromb Vasc Biol; 2006 Jan; 26(1):117-23. PubMed ID: 16254205
[TBL] [Abstract][Full Text] [Related]
6. Simvastatin inhibits NOR-1 expression induced by hyperlipemia by interfering with CREB activation.
Crespo J; Martínez-González J; Rius J; Badimon L
Cardiovasc Res; 2005 Aug; 67(2):333-41. PubMed ID: 16005304
[TBL] [Abstract][Full Text] [Related]
7. Low-density lipoproteins impair migration of human coronary vascular smooth muscle cells and induce changes in the proteomic profile of myosin light chain.
Padró T; Peña E; García-Arguinzonis M; Llorente-Cortes V; Badimon L
Cardiovasc Res; 2008 Jan; 77(1):211-20. PubMed ID: 18006454
[TBL] [Abstract][Full Text] [Related]
8. Aggregated low-density lipoprotein induces LRP1 stabilization through E3 ubiquitin ligase CHFR downregulation in human vascular smooth muscle cells.
Cal R; García-Arguinzonis M; Revuelta-López E; Castellano J; Padró T; Badimon L; Llorente-Cortés V
Arterioscler Thromb Vasc Biol; 2013 Feb; 33(2):369-77. PubMed ID: 23241409
[TBL] [Abstract][Full Text] [Related]
9. Sirolimus increases tissue factor expression but not activity in cultured human vascular smooth muscle cells.
Zhu S; Viswambharan H; Gajanayake T; Ming XF; Yang Z
BMC Cardiovasc Disord; 2005 Jul; 5():22. PubMed ID: 16018822
[TBL] [Abstract][Full Text] [Related]
10. Role of RhoA inactivation in reduced cell proliferation of human airway smooth muscle by simvastatin.
Takeda N; Kondo M; Ito S; Ito Y; Shimokata K; Kume H
Am J Respir Cell Mol Biol; 2006 Dec; 35(6):722-9. PubMed ID: 16858009
[TBL] [Abstract][Full Text] [Related]
11. Sterol regulatory element-binding protein-2 negatively regulates low density lipoprotein receptor-related protein transcription.
Llorente-Cortés V; Costales P; Bernués J; Camino-Lopez S; Badimon L
J Mol Biol; 2006 Jun; 359(4):950-60. PubMed ID: 16697011
[TBL] [Abstract][Full Text] [Related]
12. UPA promotes lipid-loaded vascular smooth muscle cell migration through LRP-1.
Lugano R; Peña E; Casani L; Badimon L; Padró T
Cardiovasc Res; 2013 Nov; 100(2):262-71. PubMed ID: 23812296
[TBL] [Abstract][Full Text] [Related]
13. Aggregated low density lipoprotein induces tissue factor by inhibiting sphingomyelinase activity in human vascular smooth muscle cells.
Camino-López S; Badimon L; González A; Canals D; Peña E; Llorente-Cortés V
J Thromb Haemost; 2009 Dec; 7(12):2137-46. PubMed ID: 19817993
[TBL] [Abstract][Full Text] [Related]
14. 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors decrease Fas ligand expression and cytotoxicity in activated human T lymphocytes.
Blanco-Colio LM; Muñoz-García B; Martín-Ventura JL; Lorz C; Díaz C; Hernández G; Egido J
Circulation; 2003 Sep; 108(12):1506-13. PubMed ID: 12952848
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of epidermal growth factor-induced RhoA translocation and invasion of human pancreatic cancer cells by 3-hydroxy-3-methylglutaryl-coenzyme a reductase inhibitors.
Kusama T; Mukai M; Iwasaki T; Tatsuta M; Matsumoto Y; Akedo H; Nakamura H
Cancer Res; 2001 Jun; 61(12):4885-91. PubMed ID: 11406567
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of RhoA/Rho-kinase pathway suppresses the expression of type I collagen induced by TGF-beta2 in human retinal pigment epithelial cells.
Itoh Y; Kimoto K; Imaizumi M; Nakatsuka K
Exp Eye Res; 2007 Mar; 84(3):464-72. PubMed ID: 17217948
[TBL] [Abstract][Full Text] [Related]
17. Prostacyclin induction by high-density lipoprotein (HDL) in vascular smooth muscle cells depends on sphingosine 1-phosphate receptors: effect of simvastatin.
González-Díez M; Rodríguez C; Badimon L; Martínez-González J
Thromb Haemost; 2008 Jul; 100(1):119-26. PubMed ID: 18612546
[TBL] [Abstract][Full Text] [Related]
18. Simvastatin Increases Fibulin-2 Expression in Human Coronary Artery Smooth Muscle Cells via RhoA/Rho-Kinase Signaling Pathway Inhibition.
Serra N; Rosales R; Masana L; Vallvé JC
PLoS One; 2015; 10(7):e0133875. PubMed ID: 26207907
[TBL] [Abstract][Full Text] [Related]
19. Withdrawal of cerivastatin induces monocyte chemoattractant protein 1 and tissue factor expression in cultured vascular smooth muscle cells.
Brandes RP; Beer S; Ha T; Busse R
Arterioscler Thromb Vasc Biol; 2003 Oct; 23(10):1794-800. PubMed ID: 12933532
[TBL] [Abstract][Full Text] [Related]
20. Simvastatin suppresses self-renewal of mouse embryonic stem cells by inhibiting RhoA geranylgeranylation.
Lee MH; Cho YS; Han YM
Stem Cells; 2007 Jul; 25(7):1654-63. PubMed ID: 17464088
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
